Hypersensitivity to Sunlight and Dysmenorrhea Controlled with Benadryl1 Report of a Case by Tyson, William G.
PRELIMINARY AND SHORT REPORTS
HYPERSENSITIVITY TO SUNLIGHT AND DYSMENORRHEA CONTROLLED
WITH BENADRYL1
REPORT OF A CASE
WILLIAM G. TYSON, M. D.
Savannah, Ga.
L. B., a colored female, age 32, 5 years ago suddenly experienced severe urticarial wheals
on all parts when exposed to even small amounts of direct sunlight (10). Up to December
31, 1945, when this patient was first seen by me, no beneficial results had been obtained from
any form of treatment. Her personal and family histories were negative for allergic
diseases. The menstrual cycle has been regular (28 day), but there was severe dysmcnorrhea.
The urticarial reactions were much exaggerated during the menstrual periods. No path-
ologic conditions were found on general physical examination.
Routine skin tests were made by the scratch technique. A positive reaction was elicited
by house dust allergen only.
Treatment during two months included hapamine, torantil, nethamine, estrogenic
hormones and adrenalin. Only adrenalin produced any benefit, and this was, as usual,
transitory. The sensitivity to light was not altered (15).
Then benadryl was given in doses of 50 mg. two times a day for three weeks, (1, 4, 6, 7,
9, 11, 12, 13). During this period the patient was able to endure direct sunlight for short
periods, experiencing only mild urticaria on the exposed parts and on the soles of the feet.
The dose of benadryl was then increased to 50 mg. four times a day for three weeks. The
patient was instructed to increase the time of exposure to direct sunlight while taking the
200 mgs. a day. A slight nervousness was experienced when the dose was increased, but
there was no urticaria when exposed to direct sunlight, even for long intervals. Treatment
was then stopped and the patient directed to use benadryl (50 mg. dose) whenever the
urticaria reappeared (1, 2, 3, 5, 8, 11).
It is also of interest to note that while taking the benadryl the patient experienced no
dysmenorrhea for two months. It is, however, difficult to evaluate the importance of en-
docrine disturbances in the etiology of urticaria (13, 14); and the possible connection be-
tween benadryl administration and the cessation of dysmenorrhea is a new observation and
still requires elucidation.
SUMMARY
1. A case of chronic urticaria elicited by hypersensitivity to sunlight is reported.
2. The urticaria was intensified during menstruation.
3. All medication previously given had failed to give relief, except for the transitory
effects of adrenalin.
4. Prompt relief was obtained with the use of benadryl, 100 to 200 mg. a day, orally,
both after exposure to sunlight and during menstruation.
5. Benadryl controlled not only the urticarial sensitivity to light, but also the severe
dysmenorrhea. The latter observation is new and requires confirmation and elucidation.
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STUDIES OF SKIN LESIONS UNDER FILTERED ULTRAVIOLET RADIATION
AFTER INTRAVENOUS INJECTION OF FLUORESCEIN'
PRELIMINARY REPORT
FRANZ HERRMANN, M.D., AND NORMAN B. KANOF, M.D.
The intravenous injection of fluorescein has been employed by Lange and Cow (1 a-d)
for investigation of the peripheral circulation. Whereas Costello and Luttenberger (2)
studied the surface of skin conditions under Ultraviolet Rays, we employed Lange's fluores..
cein technique for the investigation of .ubsurf ace peculiarities produced chiefly by circu-
latory changes in cutaneous lesions. Sixty-six patients with various derrnatoses were
studied under a special lamp (ib) after injections of "Fluorescite". Photographs were
'From the New York Skin and Cancer Unit, New York Post Graduate Medical School
and Hospital, Columbia University, New York. This work has been made possible through
a grant from Wallace Laboratories, Inc., New Brunswick, New Jersey.
'Aqueous solution of 5% fluorescein and 5% sodium bicarbonate. Dosage is 1.3 cc. per
10 kg. body wt.
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